Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 148 entries
Sorted by: Best Match Show Resources per page
ATTRIBUTES OF FORM IN THE BUILT ENVIRONMENT THAT INFLUENCE PERCEIVED WALKABILITY.

Journal of architectural and planning research

Oreskovic NM, Charles PR, Shepherd DT, Nelson KP, Bar M.
PMID: 25554719
J Archit Plann Res. 2014;31(3):218-232.

A recent focus of design and building regulations, including form-based codes and the Leadership in Energy and Environmental Design for Neighborhood Development rating system, has been on promoting pedestrian activity. This study assessed perceptions of walkability for residential and...

Cite
Oreskovic NM, Charles PR, Shepherd DT, et al. ATTRIBUTES OF FORM IN THE BUILT ENVIRONMENT THAT INFLUENCE PERCEIVED WALKABILITY. J Archit Plann Res. 2014;31(3):218-232
Oreskovic, N. M., Charles, P. R., Shepherd, D. T., Nelson, K. P., & Bar, M. (2014). ATTRIBUTES OF FORM IN THE BUILT ENVIRONMENT THAT INFLUENCE PERCEIVED WALKABILITY. Journal of architectural and planning research, 31(3), 218-232.
Oreskovic, Nicolas M, et al. "ATTRIBUTES OF FORM IN THE BUILT ENVIRONMENT THAT INFLUENCE PERCEIVED WALKABILITY." Journal of architectural and planning research vol. 31,3 (2014): 218-232.
Oreskovic NM, Charles PR, Shepherd DT, Nelson KP, Bar M. ATTRIBUTES OF FORM IN THE BUILT ENVIRONMENT THAT INFLUENCE PERCEIVED WALKABILITY. J Archit Plann Res. 2014;31(3):218-232. PMID: 25554719; PMCID: PMC4278351.
Copy Download .nbib Format: NLM
The Case for Addressing Operator Fatigue.

Review of human factors and ergonomics

Duffy JF, Zitting KM, Czeisler CA.
PMID: 26056516
Rev Hum Factors Ergon. 2015 Jun;10(1):29-78. doi: 10.1177/1557234X15573949.

Sleep deficiency, which can be caused by acute sleep deprivation, chronic insufficient sleep, untreated sleep disorders, disruption of circadian timing, and other factors, is endemic in the U.S., including among professional and non-professional drivers and operators. Vigilance and attention...

Cite
Duffy JF, Zitting KM, Czeisler CA. The Case for Addressing Operator Fatigue. Rev Hum Factors Ergon. 2015;10(1):29-78doi: 10.1177/1557234X15573949.
Duffy, J. F., Zitting, K. M., & Czeisler, C. A. (2015). The Case for Addressing Operator Fatigue. Review of human factors and ergonomics, 10(1), 29-78. https://doi.org/10.1177/1557234X15573949
Duffy, Jeanne F, et al. "The Case for Addressing Operator Fatigue." Review of human factors and ergonomics vol. 10,1 (2015): 29-78. doi: https://doi.org/10.1177/1557234X15573949
Duffy JF, Zitting KM, Czeisler CA. The Case for Addressing Operator Fatigue. Rev Hum Factors Ergon. 2015 Jun;10(1):29-78. doi: 10.1177/1557234X15573949. PMID: 26056516; PMCID: PMC4457397.
Copy Download .nbib Format: NLM
Admission vitamin D status is associated with discharge destination in critically ill surgical patients.

Annals of intensive care

Brook K, Camargo CA, Christopher KB, Quraishi SA.
PMID: 26380991
Ann Intensive Care. 2015 Dec;5(1):23. doi: 10.1186/s13613-015-0065-9. Epub 2015 Sep 17.

BACKGROUND: Discharge destination after critical illness is increasingly recognized as a valuable patient-centered outcome. Recently, vitamin D status has been shown to be associated with important outcomes such as length of stay (LOS) and mortality in intensive care unit...

Cite
Brook K, Camargo CA, Christopher KB, et al. Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Ann Intensive Care. 2015;5(1):23doi: 10.1186/s13613-015-0065-9.
Brook, K., Camargo, C. A., Christopher, K. B., & Quraishi, S. A. (2015). Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Annals of intensive care, 5(1), 23. https://doi.org/10.1186/s13613-015-0065-9
Brook, Karolina, et al. "Admission vitamin D status is associated with discharge destination in critically ill surgical patients." Annals of intensive care vol. 5,1 (2015): 23. doi: https://doi.org/10.1186/s13613-015-0065-9
Brook K, Camargo CA, Christopher KB, Quraishi SA. Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Ann Intensive Care. 2015 Dec;5(1):23. doi: 10.1186/s13613-015-0065-9. Epub 2015 Sep 17. PMID: 26380991; PMCID: PMC4573737.
Copy Download .nbib Format: NLM
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.

Neurology(R) neuroimmunology & neuroinflammation

Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M, Zhang JR, McGrath MS, Ludington E, Appel SH, Azhir A.
PMID: 25884010
Neurol Neuroimmunol Neuroinflamm. 2015 Apr 09;2(3):e100. doi: 10.1212/NXI.0000000000000100. eCollection 2015 Jun.

OBJECTIVE: To assess the safety, tolerability, and preliminary efficacy of NP001, a novel immune regulator of inflammatory monocytes/macrophages, for slowing progression of amyotrophic lateral sclerosis (ALS).METHODS: This was a phase 2 randomized, double-blind, placebo-controlled trial of NP001 in 136...

Cite
Miller RG, Block G, Katz JS, et al. Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e100doi: 10.1212/NXI.0000000000000100.
Miller, R. G., Block, G., Katz, J. S., Barohn, R. J., Gopalakrishnan, V., Cudkowicz, M., Zhang, J. R., McGrath, M. S., Ludington, E., Appel, S. H., Azhir, A. (2015). Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS. Neurology(R) neuroimmunology & neuroinflammation, 2(3), e100. https://doi.org/10.1212/NXI.0000000000000100
Miller, Robert G, et al. "Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS." Neurology(R) neuroimmunology & neuroinflammation vol. 2,3 (2015): e100. doi: https://doi.org/10.1212/NXI.0000000000000100
Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M, Zhang JR, McGrath MS, Ludington E, Appel SH, Azhir A. Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS. Neurol Neuroimmunol Neuroinflamm. 2015 Apr 09;2(3):e100. doi: 10.1212/NXI.0000000000000100. eCollection 2015 Jun. PMID: 25884010; PMCID: PMC4396529.
Copy Download .nbib Format: NLM
Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients.

Journal of intensive care

Mahato B, Otero TM, Holland CA, Giguere PT, Bajwa EK, Camargo CA, Quraishi SA.
PMID: 27330812
J Intensive Care. 2016 Jun 17;4:40. doi: 10.1186/s40560-016-0165-0. eCollection 2016.

BACKGROUND: The Deyo-Charlson Comorbidity Index (DCCI) has low predictive value in the intensive care unit (ICU). Our goal was to determine whether addition of 25-hydroxyvitamin D (25OHD) levels to the DCCI improved 90-day mortality prediction in critically ill patients.METHODS:...

Cite
Mahato B, Otero TM, Holland CA, et al. Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients. J Intensive Care. 2016;4:40doi: 10.1186/s40560-016-0165-0.
Mahato, B., Otero, T. M., Holland, C. A., Giguere, P. T., Bajwa, E. K., Camargo, C. A., & Quraishi, S. A. (2016). Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients. Journal of intensive care, 440. https://doi.org/10.1186/s40560-016-0165-0
Mahato, Bisundev, et al. "Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients." Journal of intensive care vol. 4 (2016): 40. doi: https://doi.org/10.1186/s40560-016-0165-0
Mahato B, Otero TM, Holland CA, Giguere PT, Bajwa EK, Camargo CA, Quraishi SA. Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients. J Intensive Care. 2016 Jun 17;4:40. doi: 10.1186/s40560-016-0165-0. eCollection 2016. PMID: 27330812; PMCID: PMC4912797.
Copy Download .nbib Format: NLM
Differential effects of motor cortical excitability and plasticity in young and old individuals: a Transcranial Magnetic Stimulation (TMS) study.

Frontiers in aging neuroscience

Bashir S, Perez JM, Horvath JC, Pena-Gomez C, Vernet M, Capia A, Alonso-Alonso M, Pascual-Leone A.
PMID: 24959141
Front Aging Neurosci. 2014 Jun 10;6:111. doi: 10.3389/fnagi.2014.00111. eCollection 2014.

Aging is associated with changes in the motor system that, over time, can lead to functional impairments and contribute negatively to the ability to recover after brain damage. Unfortunately, there are still many questions surrounding the physiological mechanisms underlying...

Cite
Bashir S, Perez JM, Horvath JC, et al. Differential effects of motor cortical excitability and plasticity in young and old individuals: a Transcranial Magnetic Stimulation (TMS) study. Front Aging Neurosci. 2014;6:111doi: 10.3389/fnagi.2014.00111.
Bashir, S., Perez, J. M., Horvath, J. C., Pena-Gomez, C., Vernet, M., Capia, A., Alonso-Alonso, M., & Pascual-Leone, A. (2014). Differential effects of motor cortical excitability and plasticity in young and old individuals: a Transcranial Magnetic Stimulation (TMS) study. Frontiers in aging neuroscience, 6111. https://doi.org/10.3389/fnagi.2014.00111
Bashir, Shahid, et al. "Differential effects of motor cortical excitability and plasticity in young and old individuals: a Transcranial Magnetic Stimulation (TMS) study." Frontiers in aging neuroscience vol. 6 (2014): 111. doi: https://doi.org/10.3389/fnagi.2014.00111
Bashir S, Perez JM, Horvath JC, Pena-Gomez C, Vernet M, Capia A, Alonso-Alonso M, Pascual-Leone A. Differential effects of motor cortical excitability and plasticity in young and old individuals: a Transcranial Magnetic Stimulation (TMS) study. Front Aging Neurosci. 2014 Jun 10;6:111. doi: 10.3389/fnagi.2014.00111. eCollection 2014. PMID: 24959141; PMCID: PMC4050736.
Copy Download .nbib Format: NLM
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.

Journal of AIDS & clinical research

Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, Koblin BA, Rouphael NG, Kalams SA, Keefer MC, Goepfert PA, Sobieszczyk ME, Mayer KH, Swann E, Liao HX, Haynes BF, Graham BS, McElrath MJ.
PMID: 26587311
J AIDS Clin Res. 2015 May;6(5). doi: 10.4172/2155-6113.1000461. Epub 2015 May 23.

BACKGROUND: Recombinant adenovirus serotype 5 (rAd5)-vectored HIV-1 vaccines have not prevented HIV-1 infection or disease and pre-existing Ad5 neutralizing antibodies may limit the clinical utility of Ad5 vectors globally. Using a rare Ad serotype vector, such as Ad35, may...

Cite
Fuchs JD, Bart PA, Frahm N, et al. Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. J AIDS Clin Res. 2015;6(5)doi: 10.4172/2155-6113.1000461.
Fuchs, J. D., Bart, P. A., Frahm, N., Morgan, C., Gilbert, P. B., Kochar, N., DeRosa, S. C., Tomaras, G. D., Wagner, T. M., Baden, L. R., Koblin, B. A., Rouphael, N. G., Kalams, S. A., Keefer, M. C., Goepfert, P. A., Sobieszczyk, M. E., Mayer, K. H., Swann, E., Liao, H. X., Haynes, B. F., Graham, B. S., McElrath, M. J. (2015). Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. Journal of AIDS & clinical research, 6(5), . https://doi.org/10.4172/2155-6113.1000461
Fuchs, Jonathan D, et al. "Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals." Journal of AIDS & clinical research vol. 6,5 (2015). doi: https://doi.org/10.4172/2155-6113.1000461
Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, Koblin BA, Rouphael NG, Kalams SA, Keefer MC, Goepfert PA, Sobieszczyk ME, Mayer KH, Swann E, Liao HX, Haynes BF, Graham BS, McElrath MJ. Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. J AIDS Clin Res. 2015 May;6(5). doi: 10.4172/2155-6113.1000461. Epub 2015 May 23. PMID: 26587311; PMCID: PMC4648371.
Copy Download .nbib Format: NLM
Prediction of Happy-Sad mood from daily behaviors and previous sleep history.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Sano A, Yu AZ, McHill AW, Phillips AJ, Taylor S, Jaques N, Klerman EB, Picard RW.
PMID: 26737854
Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:6796-9. doi: 10.1109/EMBC.2015.7319954.

We collected and analyzed subjective and objective data using surveys and wearable sensors worn day and night from 68 participants for ~30 days each, to address questions related to the relationships among sleep duration, sleep irregularity, self-reported Happy-Sad mood...

Cite
Sano A, Yu AZ, McHill AW, et al. Prediction of Happy-Sad mood from daily behaviors and previous sleep history. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:6796-9doi: 10.1109/EMBC.2015.7319954.
Sano, A., Yu, A. Z., McHill, A. W., Phillips, A. J., Taylor, S., Jaques, N., Klerman, E. B., & Picard, R. W. (2015). Prediction of Happy-Sad mood from daily behaviors and previous sleep history. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20156796-9. https://doi.org/10.1109/EMBC.2015.7319954
Sano, Akane, et al. "Prediction of Happy-Sad mood from daily behaviors and previous sleep history." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2015 (2015): 6796-9. doi: https://doi.org/10.1109/EMBC.2015.7319954
Sano A, Yu AZ, McHill AW, Phillips AJ, Taylor S, Jaques N, Klerman EB, Picard RW. Prediction of Happy-Sad mood from daily behaviors and previous sleep history. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:6796-9. doi: 10.1109/EMBC.2015.7319954. PMID: 26737854; PMCID: PMC4768795.
Copy Download .nbib Format: NLM
Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study.

Receptors & clinical investigation

Gaffin JM, Phipatanakul W.
PMID: 25590045
Receptors Clin Investig. 2014;1(1). doi: 10.14800/rci.15.

Asthma is the most common chronic illness of childhood and inner city residents suffer a disproportionately high rate of asthma diagnosis and asthma morbidity. The School Inner City Asthma Study investigates the school classroom based environmental exposures that may...

Cite
Gaffin JM, Phipatanakul W. Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study. Receptors Clin Investig. 2014;1(1)doi: 10.14800/rci.15.
Gaffin, J. M., & Phipatanakul, W. (2014). Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study. Receptors & clinical investigation, 1(1), . https://doi.org/10.14800/rci.15
Gaffin, Jonathan M, and Phipatanakul, Wanda. "Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study." Receptors & clinical investigation vol. 1,1 (2014). doi: https://doi.org/10.14800/rci.15
Gaffin JM, Phipatanakul W. Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study. Receptors Clin Investig. 2014;1(1). doi: 10.14800/rci.15. PMID: 25590045; PMCID: PMC4289902.
Copy Download .nbib Format: NLM
Mesh-based Monte Carlo method using fast ray-tracing in Plücker coordinates.

Biomedical optics express

Fang Q.
PMID: 21170299
Biomed Opt Express. 2010 Aug 02;1(1):165-75. doi: 10.1364/BOE.1.000165. Epub 2010 Jul 15.

We describe a fast mesh-based Monte Carlo (MC) photon migration algorithm for static and time-resolved imaging in 3D complex media. Compared with previous works using voxel-based media discretization, a mesh-based approach can be more accurate in modeling targets with...

Cite
Fang Q. Mesh-based Monte Carlo method using fast ray-tracing in Plücker coordinates. Biomed Opt Express. 2010;1(1):165-75doi: 10.1364/BOE.1.000165.
Fang, Q. (2010). Mesh-based Monte Carlo method using fast ray-tracing in Plücker coordinates. Biomedical optics express, 1(1), 165-75. https://doi.org/10.1364/BOE.1.000165
Fang, Qianqian. "Mesh-based Monte Carlo method using fast ray-tracing in Plücker coordinates." Biomedical optics express vol. 1,1 (2010): 165-75. doi: https://doi.org/10.1364/BOE.1.000165
Fang Q. Mesh-based Monte Carlo method using fast ray-tracing in Plücker coordinates. Biomed Opt Express. 2010 Aug 02;1(1):165-75. doi: 10.1364/BOE.1.000165. Epub 2010 Jul 15. PMID: 21170299; PMCID: PMC3003331.
Copy Download .nbib Format: NLM
Back to the future: studying cholera pathogenesis using infant rabbits.

mBio

Ritchie JM, Rui H, Bronson RT, Waldor MK.
PMID: 20689747
mBio. 2010 May 18;1(1). doi: 10.1128/mBio.00047-10.

Cholera is a severe diarrheal disease, caused by Vibrio cholerae, for which there has been no reproducible, nonsurgical animal model. Here, we report that orogastric inoculation of V. cholerae into 3-day-old rabbits pretreated with cimetidine led to lethal, watery...

Cite
Ritchie JM, Rui H, Bronson RT, et al. Back to the future: studying cholera pathogenesis using infant rabbits. mBio. 2010;1(1)doi: 10.1128/mBio.00047-10.
Ritchie, J. M., Rui, H., Bronson, R. T., & Waldor, M. K. (2010). Back to the future: studying cholera pathogenesis using infant rabbits. mBio, 1(1), . https://doi.org/10.1128/mBio.00047-10
Ritchie, Jennifer M, et al. "Back to the future: studying cholera pathogenesis using infant rabbits." mBio vol. 1,1 (2010). doi: https://doi.org/10.1128/mBio.00047-10
Ritchie JM, Rui H, Bronson RT, Waldor MK. Back to the future: studying cholera pathogenesis using infant rabbits. mBio. 2010 May 18;1(1). doi: 10.1128/mBio.00047-10. PMID: 20689747; PMCID: PMC2912669.
Copy Download .nbib Format: NLM
Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles.

Frontiers in physiology

Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J, Kuo WP.
PMID: 22661955
Front Physiol. 2012 May 28;3:162. doi: 10.3389/fphys.2012.00162. eCollection 2012.

Microvesicles are nano-sized lipid vesicles released by all cells in vivo and in vitro. They are released physiologically under normal conditions but their rate of release is higher under pathological conditions such as tumors. Once released they end up...

Cite
Momen-Heravi F, Balaj L, Alian S, et al. Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol. 2012;3:162doi: 10.3389/fphys.2012.00162.
Momen-Heravi, F., Balaj, L., Alian, S., Trachtenberg, A. J., Hochberg, F. H., Skog, J., & Kuo, W. P. (2012). Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Frontiers in physiology, 3162. https://doi.org/10.3389/fphys.2012.00162
Momen-Heravi, Fatemeh, et al. "Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles." Frontiers in physiology vol. 3 (2012): 162. doi: https://doi.org/10.3389/fphys.2012.00162
Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J, Kuo WP. Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol. 2012 May 28;3:162. doi: 10.3389/fphys.2012.00162. eCollection 2012. PMID: 22661955; PMCID: PMC3362089.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 148 entries